Neutra acquires cutting-edge developer of smoke-free nutraceutical delivery systems

Published on February 11, 2014 at 7:56 AM · No Comments

Neutra Corp. (OTCBB: NTRR), a fast-growing provider of all-natural wellness solutions, announced today that it acquired Diamond Anvil Designs (DA), a cutting-edge developer of smoke-free nutraceutical delivery systems.

Based in Los Angeles, Diamond Anvil makes customizable vapor pens that can be adapted to deliver a variety of nutraceutical substances, including dry herbs, oils and waxes. The lightweight, portable delivery systems represent a leap forward in vaporization technology thanks to customizable power levels, multi-substance vaporization capacity and best-in-class durability. NTRR also plans to include an ironclad warranty offer with each vape pen purchase.

The company's acquisition is a major coup for NTRR as it works to expand its footprint in the rapidly growing market for smoke-free delivery systems and accessories. Soon, new and improved Diamond Anvil Designs products will be showcased at nutraceutical expos and conventions across the country.

"We've been conducting an exhaustive search for the right acquisition in the personal vaporizer pen and e-cig space for some time, and Diamond Anvil is the innovative business we've been looking for," said NTRR CEO Sydney Jim. "Along with the brand, we're bringing in a stable of cutting-edge products that are designed to appeal to serious nutraceutical patients seeking better, easier, and more effective treatment."

Smoke-free delivery systems have exploded in popularity with nutraceutical users in recent years, with vaporizer pens, throat sprays, oral capsules, edibles and other innovations replacing pipes and cigarettes altogether for many patients. These breakthroughs deliver the same therapeutic effects of the herbs and extracts without the potential dangers and restrictions associated with smoking.

Source: Neutra Corp.

Posted in: Business / Finance | Device / Technology News

Tags: , , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post